Epilepsy
📧 Sign up to get email alerts when something new happens for Epilepsy.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2012-04-26FDA Approved: LEVETIRACETAM — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for levetiracetam by Aurobindo Pharma Limited, approving this generic product under the ANDA.
-
FDA approval · 2012-04-25FDA Approved: LEVETIRACETAM — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for levetiracetam from BluePoint Laboratories under an ANDA. This indicates a formal approval of the…
-
FDA approval · 2012-04-25FDA Approved: LAMOTRIGINE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for lamotrigine by Aurobindo Pharma Limited. This action approves changes to the generic lamotri…
-
FDA approval · 2012-04-11FDA Approved: GABAPENTIN — Supplemental Application (Exelan Pharmaceuticals, Inc.)
The FDA approved a supplemental application for gabapentin submitted by Exelan Pharmaceuticals, Inc. This action confirms an approved supple…
-
FDA approval · 2012-04-11FDA Approved: GABAPENTIN — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a supplemental application for gabapentin submitted by Zydus Pharmaceuticals USA Inc. under ANDA 078926.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-04-11FDA Approved: LEVETIRACETAM — Original Application (QUAGEN PHARMACEUTICALS LLC)
FDA approved the original application for levetiracetam by Quagen Pharmaceuticals LLC, making a generic version of the antiepileptic availab…
-
FDA approval · 2012-04-06FDA Approved: LEVETIRACETAM — Original Application (Hospira, Inc.)
FDA approved Hospira, Inc.'s original ANDA for levetiracetam, establishing a generic version of the anti-seizure medication Keppra. Levetira…
-
FDA approval · 2012-03-27FDA Approved: LAMOTRIGINE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
The FDA approved a supplemental application for a Lamotrigine product from Unichem Pharmaceuticals (USA), Inc., effectively approving a gene…
-
FDA approval · 2012-03-26FDA Approved: LAMOTRIGINE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for lamotrigine from Glenmark Pharmaceuticals (ANDA 079099).
-
FDA approval · 2012-03-23FDA Approved: GABAPENTIN — Original Application (Amneal Pharmaceuticals LLC)
The FDA approved Amneal Pharmaceuticals' original Abbreviated New Drug Application for gabapentin, authorizing a generic gabapentin product.
-
CLINICAL_TRIALS withdrawal · 2012-03-20Clinical Trial Update: Open Label Study (Everyone Who Participates Receives Drug) to Further Determine How Safe and Effective Oral Treatment of Seletracetam is in Patients With Refractory Epilepsy. [Phase 3]
The Phase 3 open-label trial of Seletracetam in refractory epilepsy has been withdrawn, according to sponsor UCB Pharma.
-
FDA approval · 2012-03-15FDA Approved: LAMOTRIGINE — Supplemental Application (Dr.Reddy's Laboratories Limited)
The FDA approved a supplemental application for lamotrigine from Dr. Reddy's Laboratories Limited. The approval concerns the generic lamotri…
-
FDA approval · 2012-03-15FDA Approved: LAMOTRIGINE — Supplemental Application (Alembic Pharmaceuticals Limited)
The FDA approved a supplemental application for Lamotrigine from Alembic Pharmaceuticals Limited, sanctioning an updated approval for the ge…
-
CLINICAL_TRIALS trial_result · 2012-03-15Clinical Trial Update: Heart Rate Changes During Normal Activity, Exercise, and Seizures in Subjects With Epilepsy
This completed clinical trial investigated how heart rate changes in people with epilepsy during normal activity, exercise, and seizures.
-
FDA approval · 2012-03-15FDA Approved: DIVALPROEX SODIUM — Original Application (Dr. Reddy's Laboratories Ltd)
The FDA approved Dr. Reddy's Laboratories' original application for divalproex sodium, a generic anticonvulsant, for use in conditions such …
-
FDA approval · 2012-03-14FDA Approved: LAMOTRIGINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for Lamotrigine from Sun Pharmaceutical Industries, Inc. The action indicates a labeling update or p…
-
CLINICAL_TRIALS trial_result · 2012-03-05Clinical Trial Update: Assessment of Suicidality in Epilepsy - Rating Tools
The document reports a completed clinical trial evaluating tools for assessing suicidality in people with epilepsy.
-
CLINICAL_TRIALS trial_result · 2012-03-01Clinical Trial Update: Scalp Nerve Blocks for Post-Craniotomy Pain [NA]
Completed clinical trial evaluating scalp nerve blocks for post-craniotomy pain.
-
FDA label_change · 2012-02-28FDA Approved: LAMOTRIGINE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a supplemental application for lamotrigine by Zydus Pharmaceuticals USA Inc., resulting in updated labeling for the product.
-
FDA approval · 2012-02-27FDA Approved: LAMOTRIGINE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a supplemental application for lamotrigine from Zydus Pharmaceuticals USA Inc.
-
CLINICAL_TRIALS research · 2012-02-20Clinical Trial Update: Coping Skills Training (CST) for Children With Chronic Health Conditions [Phase 2]
This update notes the completion of a Phase 2 clinical trial of Coping Skills Training for children with chronic health conditions, includin…
-
CLINICAL_TRIALS research · 2012-02-15Clinical Trial Update: Personalizing Health Outcome in Epilepsy Now - An Introduction to Clinical Services [NA]
This entry provides an update on a clinical trial aimed at personalizing health outcomes in epilepsy and introduces related clinical service…
-
CLINICAL_TRIALS trial_result · 2012-02-14Clinical Trial Update: Clinical and Economic Burden of Uncontrolled Epilepsy: Analyses From a Medicaid Database and a Private Health Plan Database
This clinical trial update analyzes the clinical and economic burden of uncontrolled epilepsy using analyses from a Medicaid database and a …
-
CLINICAL_TRIALS trial_result · 2012-02-14Clinical Trial Update: Catamenial Epilepsy Treatment [Phase 2]
A Phase 2 clinical trial update for a catamenial epilepsy treatment; the document lists the sponsor and condition but the trial status is un…
-
CLINICAL_TRIALS trial_result · 2012-02-09Clinical Trial Update: Clobazam in Patients With Lennox-Gastaut Syndrome [Phase 3]
Phase 3 clinical trial results for clobazam in Lennox-Gastaut syndrome; the study is completed and results were posted in 2012.